IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

Myocardial Infarction: Disease Mechanisms and Therapeutic Perspectives

Myocardial Infarction: Disease Mechanisms and Therapeutic Perspectives
View Sample PDF
Author(s): Kalyan C. Chapalamadugu (University of South Florida, USA), Samhitha Gudla (University of South Florida, USA), Rakesh Kukreja (Virginia Commonwealth University, USA)and Srinivas M. Tipparaju (University of South Florida, USA)
Copyright: 2017
Pages: 22
Source title: Emerging Applications, Perspectives, and Discoveries in Cardiovascular Research
Source Author(s)/Editor(s): Ashim Malhotra (Pacific University, USA)and Shivani Soni (California State University, Fullerton, USA & Chapman University, USA & Alabama State University, USA)
DOI: 10.4018/978-1-5225-2092-4.ch008

Purchase

View Myocardial Infarction: Disease Mechanisms and Therapeutic Perspectives on the publisher's website for pricing and purchasing information.

Abstract

Myocardial infarction (MI) is a major cardiovascular disease (CVD) and ranks among the leading causes of morbidity and mortality in humans, worldwide. Despite advances in disease prevention and treatment strategies, majority of the developed and developing world's suffer higher disease burden from MI, and incur billions of dollars in healthcare costs (Murray et al., 2015). Global estimates from 2013 show that MI is the major cardiovascular disease (CVD), and that deaths due to MI accounted for nearly half of the 17 million CVD mortalities (GBD, 2013; Mortality and Causes of Death Collaborators, 2015). Within the United States, MI top's the chart of both communicable and non-communicable diseases in terms of health loss that it is estimated to have inflicted in the population (Murray, et al., 2015). It has been estimated that every 2 minutes, three Americans suffer from myocardial infarction (MI), primary cause of MI being coronary blood flow obstruction and myocardial damage. The annual estimates of MI incidence in USA are approximately three quarter million a year while almost two-thirds of these cases represent new attacks (Mozaffarian, et al., 2015). Collectively, MI continues to lead the charts for CVD incidence rates, health loss, mortalities thereby putting enormous strain on healthcare system.

Related Content

Ranjit Barua, Sudipto Datta. © 2024. 16 pages.
Aminabee Shaik. © 2024. 25 pages.
Sharan Kumar Shetty, Cristi Spulbar, Birău Ramona. © 2024. 67 pages.
Mubeen Fatima, Safdar Hussain, Iqra Zulfiqar, Iqra Shehzadi, Momal Babar, Tehseen Fatima. © 2024. 26 pages.
Mubeen Fatima, Safdar Hussain, Momal Babar, Nosheen Mushtaq, Tehseen Fatima. © 2024. 26 pages.
Pam Copeland. © 2024. 6 pages.
Sumit Kumar, Tenzin Dolma, Sonali Das Gupta. © 2024. 23 pages.
Body Bottom